Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

October 18, 2025

Study Completion Date

March 18, 2026

Conditions
Multiple Sclerosis
Interventions
DEVICE

Eye-Tracking

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Trial Locations (1)

H4A 3T4

Genge Partners, Inc., Montreal

Sponsors
All Listed Sponsors
lead

Innodem Neurosciences

INDUSTRY

NCT06283524 - Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis | Biotech Hunter | Biotech Hunter